Back to MDGL
Janus Henderson Group Ltd. → MDGL
Janus Henderson Group Ltd. MDGL Position History
Madrigal Pharmaceuticals, Inc. • Healthcare
Quarters held
22
Latest value
$192K
Q3 2026
Peak value
$1B
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $904.2M |
| Q4 2025 | $841K |
| Q4 2025 | $8M |
| Q4 2025 | $5.1M |
| Q1 2026 | $8.1M |
| Q1 2026 | $4.6M |
| Q1 2026 | $8M |
| Q1 2026 | $219K |
| Q1 2026 | $1B |
| Q1 2026 | $743K |
| Q1 2026 | $8M |
| Q1 2026 | $219K |
| Q1 2026 | $4.6M |
| Q1 2026 | $1B |
| Q1 2026 | $8.1M |
| Q1 2026 | $743K |
| Q3 2026 | $972.2M |
| Q3 2026 | $3.7M |
| Q3 2026 | $9M |
| Q3 2026 | $8M |
| Q3 2026 | $794K |
| Q3 2026 | $192K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $192K | 381 | — | — |
| Q3 2026 | $794K | 1.6K | — | — |
| Q3 2026 | $8M | 15.8K | — | — |
| Q3 2026 | $9M | 17.8K | — | — |
| Q3 2026 | $3.7M | 7.4K | — | — |
| Q3 2026 | $972.2M | 1.93M | — | — |
| Q1 2026 | $743K | 1.4K | — | — |
| Q1 2026 | $8.1M | 15.5K | — | — |
| Q1 2026 | $1B | 1.98M | — | — |
| Q1 2026 | $4.6M | 8.8K | — | — |
| Q1 2026 | $219K | 419 | — | — |
| Q1 2026 | $8M | 15.4K | — | — |
| Q1 2026 | $743K | 1.4K | — | — |
| Q1 2026 | $1B | 1.98M | — | — |
| Q1 2026 | $219K | 419 | — | — |
| Q1 2026 | $8M | 15.4K | — | — |
| Q1 2026 | $4.6M | 8.8K | — | — |
| Q1 2026 | $8.1M | 15.5K | — | — |
| Q4 2025 | $5.1M | 8.8K | — | — |
| Q4 2025 | $8M | 13.7K | — | — |
| Q4 2025 | $841K | 1.4K | — | — |
| Q4 2025 | $904.2M | 1.56M | — | — |